MEMO PLUS GOLD Bacopa Monniera Extract 125mg Capsule 1's
FOODSUPP-FR-4000008457622-1pc
- View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
FOODSUPP-FR-4000008457622-1pc
|
In stock
|
₱1600 |
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Sellers of this product
Features
Brand
Memo Plus Gold
Full Details
Dosage Strength
125mg
Drug Ingredients
- Bacopa Monniera
Drug Packaging
Capsule 1's
Generic Name
Bacopa Monniera Extract
Dosage Form
Capsule
Registration Number
FR-4000008457622
Drug Classification
Food Supplements
Description
Indications/Uses
Adjuvant therapy for those suffering from forgetfulness, shortened memory retention and symptoms of senility. It can also help increase the comprehension and memory levels of students and people in the workforce. Memo Plus Gold sets a high standard in memory enhancement. By improving memory and information retention, Memo Plus Gold is ideal for those suffering from attention deficit hyperactivity disorder (ADHD) and Age Associated Memory Impairment (AAMI).
Dosage/Direction for Use
1 cap twice a day.
Administration: Best taken after food.
Administration: Best taken after food.
Administration
Should be taken on an empty stomach: Best taken after food.
Special Precautions
Patients on blood-thinning medicines like warfarin or high dose of aspirin should consult their physician before starting on Memo Plus Gold.
Storage
Store below 25°C. Protect from moisture.
Action
Memo Plus Gold is an all-natural herbal supplement developed from an ancient Ayurvedic formula. It contains the extract of Brahmi or Bacopa monniera, a plant commonly found along marshes and pond edges that has been used for hundreds of years to increase information retention, improve learning and provide a feeling of well-being. Brahmi (scientific name: Bacopa monniera) belongs to the Scrophulariaceac family. Manufactured under a process that meets the stringent World Health Organization's guidelines, Memo Plus Gold has been approved as a safe traditional remedy.
Mode of Action: Memo Plus Gold enhances the brain's cholinergic neurotransmitter system. This helps improve the efficiency of nerve impulse transmission by strengthening the neurons' synaptic activity. Bacopa monniera boosts the protein kinase activity while increasing the protein and serotonin levels in the hippocampus- the brain area associated with memory formation.
Memo Plus Gold reduces stress and anxiety, making the mind more susceptible to absorbing and maintaining new information. With its unique benefits, Memo Plus Gold is ideal for students of all ages, professionals, homemakers and the elderly.
Clinical Tests: The Central Drug Research Institute (CDRI), a premier drug research laboratory based in Lucknow, India, started researching and analyzing the Brahmi plant in 1951. In 1963, two active memory-enhancing molecules were isolated and identified as Bacosides A and B. Together, they provide memory enhancement that is more effective than that provided by Ginkgo biloba.
Placebo-controlled double-blind phase II clinical trials were held by the Central Drug Research Institute on children with attention deficit hyperactivity disorder (ADHD). Additional studies were done for the elderly with age associated memory impairment (AAMI). Both tests proved that Memo Plus Gold is safe to use and very effective.
At the Swinburne University in Australia, double-blind randomized placebo-controlled studies were conducted. Tests results showed that Brahmi significantly improved visual information processing. These findings were published in Psychopharmacology (2001) 156: 481-484.
A similar double-blind, randomized placebo-controlled test was done at the University of Wollongong in Wollongong, Australia. The results, published in Neuropsychopharmacology 2002, clearly showed a significant effect on the retention of new information, the speed of information processing, verbal learning rate and memory consolidation.
Mode of Action: Memo Plus Gold enhances the brain's cholinergic neurotransmitter system. This helps improve the efficiency of nerve impulse transmission by strengthening the neurons' synaptic activity. Bacopa monniera boosts the protein kinase activity while increasing the protein and serotonin levels in the hippocampus- the brain area associated with memory formation.
Memo Plus Gold reduces stress and anxiety, making the mind more susceptible to absorbing and maintaining new information. With its unique benefits, Memo Plus Gold is ideal for students of all ages, professionals, homemakers and the elderly.
Clinical Tests: The Central Drug Research Institute (CDRI), a premier drug research laboratory based in Lucknow, India, started researching and analyzing the Brahmi plant in 1951. In 1963, two active memory-enhancing molecules were isolated and identified as Bacosides A and B. Together, they provide memory enhancement that is more effective than that provided by Ginkgo biloba.
Placebo-controlled double-blind phase II clinical trials were held by the Central Drug Research Institute on children with attention deficit hyperactivity disorder (ADHD). Additional studies were done for the elderly with age associated memory impairment (AAMI). Both tests proved that Memo Plus Gold is safe to use and very effective.
At the Swinburne University in Australia, double-blind randomized placebo-controlled studies were conducted. Tests results showed that Brahmi significantly improved visual information processing. These findings were published in Psychopharmacology (2001) 156: 481-484.
A similar double-blind, randomized placebo-controlled test was done at the University of Wollongong in Wollongong, Australia. The results, published in Neuropsychopharmacology 2002, clearly showed a significant effect on the retention of new information, the speed of information processing, verbal learning rate and memory consolidation.
MedsGo Class
Supplements & Adjuvant Therapy
Please sign in so that we can notify you about a reply